Patent ID: 9585834
Date: 2017-03-07
CPC Classifications: A61K,A61M,A61P

Claim:
1. A powder formulation for inhalation comprising glycopyrrolate, magnesium stearate and lactose, wherein the magnesium stearate is attached to the surface of particles of the glycopyrrolate and the magnesium stearate is attached to the surface of particles of the lactose, wherein when the magnesium stearate is added to the particles of the glycopyrrolate, the amount of magnesium stearate on the surface of the particles of the glycopyrrolate is 3 to 8 wt % of the weight of the particles of the glycopyrrolate, and wherein the magnesium stearate is added to the particles of the lactose, the amount of magnesium stearate on the surface of the particles of the lactose is 0.01 to 30 wt % of the weight of the particles of lactose.